Welcome to our dedicated page for NATIONAL HEALTH INVESTORS SEC filings (Ticker: NHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATIONAL HEALTH INVESTORS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATIONAL HEALTH INVESTORS's regulatory disclosures and financial reporting.
BlackRock, Inc. amends a Schedule 13G to report beneficial ownership of National Health Investors Inc. common stock. The filing states 8,523,688 shares beneficially owned, representing 17.6% of the class as of 06/30/2026. The filing lists 8,387,095 shares with sole voting power and cites an iShares Core S&P Small‑Cap ETF position exceeding 5%.
NATIONAL HEALTH INVESTORS INC reported the initial holdings of its Chief Financial Officer, Todd Michael Siefert, on a Form 3. He directly owns 3,048 shares of common stock and holds three stock option awards over 16,668, 16,666 and 16,666 underlying common shares, each with a $71.76 exercise price and expiring on June 1, 2031. A related restricted stock grant vests in three equal annual installments starting June 1, 2027, subject to his continued service through each vesting date.
National Health Investors, Inc. completed a major asset sale to an affiliate of National HealthCare Corporation. The company sold the land, facilities and improvements for 32 skilled nursing facilities and three independent living facilities for a total purchase price of $560 million.
The buyer group, led by NHC/OP, L.P., already leased these 35 facilities under a long-standing master lease. A Special Committee of independent, non‑interested directors reviewed and unanimously approved the related‑party transaction. At closing, the master lease was terminated for all facilities except four skilled nursing facilities in Florida, which were assigned to an NHC subsidiary.
National Health Investors, Inc. approved a new change in control severance agreement for Chief Financial Officer Todd Siefert, effective July 1, 2026. If his employment is terminated without cause or he resigns for good reason in connection with a change in control, he becomes eligible for substantial protections.
These benefits include a lump-sum payment equal to 2.0 times the average of his recent annual base salary and bonus, a separate lump-sum bonus payment based on target or actual performance, up to 18 months of continued COBRA health coverage, and full vesting of time-based equity awards. In return, Siefert is subject to non-compete, non-solicitation, and confidentiality obligations, including 12 months of post-termination non-compete and non-solicitation if severance is paid.
NATIONAL HEALTH INVESTORS INC director Robert A. McCabe Jr. reported an open-market purchase of 890 shares of common stock at $71.6485 per share. Following this transaction, he directly owns 44,158.96 shares. This filing reflects a modest increase in his personal investment in the company.
NATIONAL HEALTH INVESTORS INC director James R. Jobe reported a bona fide gift of 225 shares of Common Stock on June 5, 2026, transferred at a price of $0.00 per share. After this gift, he directly holds 33,272 Common Stock shares according to the filing.
National Health Investors CEO and President D. Eric Mendelsohn bought 1,500 shares of common stock in an open-market purchase at $68.84 per share. After this transaction, he directly owns 133,316 shares, indicating a small increase in his personal stake in the company.
National Health Investors, Inc. provided an update on its previously announced sale of real estate to affiliates of National HealthCare Corporation. The company has a Purchase and Sale Agreement to transfer 32 skilled nursing facilities and three independent living facilities that are currently leased to the buyer group.
On May 26, 2026, the parties received early termination of the Hart-Scott-Rodino antitrust waiting period, removing a key regulatory condition. That same day, the purchaser parties waived their rights to terminate the agreement during the contractual review period, which therefore ended.
The company now anticipates closing the transaction on or about July 1, 2026, subject to the remaining conditions in the agreement. The filing also highlights customary forward-looking statement cautions, noting that closing is not assured and pointing to existing risk factor disclosures in prior SEC reports.
National Health Investors, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 27, 2026. A quorum was reached, with 42,386,953 common shares represented, or about 87.46% of the 48,459,369 shares entitled to vote as of the March 27, 2026 record date.
All seven director nominees were elected to serve until the 2027 annual meeting, each receiving significantly more votes for than against. Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers.
In addition, stockholders ratified the selection of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with a large majority of votes cast in favor.
NATIONAL HEALTH INVESTORS INC CFO and EVP Finance John L. Spaid reported a small tax-related share disposition. On May 5, 2026, 314 shares of common stock were withheld by the company at $73.09 per share to cover tax obligations tied to vesting restricted stock. After this withholding, he directly holds about 56,286.6372 shares.